Grove Bank & Trust’s Chemours CC Stock Holding History

Grove Bank & Trust’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-30	Closed	-$1K	–	586
2017 Q2	$1K	Buy	+30	New	+$1.18K	﹤0.01%	657
2016 Q1	–	Sell	-20	Closed	–	–	278
2015 Q4	$0	Buy	+20	New	+$128	﹤0.01%	344

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Grove Bank & Trust's CC Position: Q3 2017 in Review

Grove Bank & Trust sold out of Chemours (CC) in Q3 2017, closing a stake of 30 shares — an estimated $1K sold.

Grove Bank & Trust first reported a position in CC in Q4 2015 and held it in 2 quarters. The position peaked at $1K in Q2 2017. 499 funds tracked by Wall St. Rank hold CC as of Q3 2017.

Grove Bank & Trust reported no remaining Chemours position as of Q3 2017 after selling out during the quarter.
Grove Bank & Trust sold 30 Chemours shares in Q3 2017, an estimated $1K.
Grove Bank & Trust first reported a position in Chemours in Q4 2015 and held it in 2 quarters.
Grove Bank & Trust's Chemours position peaked at $1K in Q2 2017.
499 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on Grove Bank & Trust's 13F filing for Q3 2017, filed 13 Nov 2017.